Parasitology and Mycology Rapid Tests and POC – Medical Devices Pipeline Assessment, 2020

Parasitology & Mycology Rapid Tests & POC comprises of rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for the detection of pathogenic protozoans and fungi. GlobalData's Medical Devices sector report, “Parasitology and Mycology Rapid Tests and POC – Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Parasitology & Mycology Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Parasitology & Mycology Rapid Tests & POC Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Parasitology & Mycology Rapid Tests & POC under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Parasitology & Mycology Rapid Tests & POC pipeline products.

Review of Recent Developments in the segment / industry

The Parasitology & Mycology Rapid Tests & POC Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Glaucoma Drainage Device sunder development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

The major companies covered in the “Parasitology & Mycology Rapid Tests & POC- Medical Devices Pipeline Assessment, 2020” report:

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

Extensive coverage of the Parasitology & Mycology Rapid Tests & POC under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Parasitology & Mycology Rapid Tests & POC and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to buy

The report enables you to:

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Parasitology & Mycology Rapid Tests & POC under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

Abingdon Health Ltd

Access Bio Inc

AdvanDx Inc

Akers Biosciences Inc

Ampath Trust

Amplino B.V.

BBB Technologies Inc

Binx Health Inc

Biomagnetics Diagnostics Corp

Biopromic AB

Biotech Resources Aust Pty Ltd

Boston University

Bruker Daltonik GmbH

Cepheid Inc

Ceres Nanosciences Inc

Chembio Diagnostic Systems Inc

CrossLife Technologies Inc

DetectoGen Inc

D-Kimia, LLC.

DxDiscovery Inc

Eiken Chemical Co Ltd

ERADA Technology Alliance Ltd

Foundation for Innovative New Diagnostics

genedrive plc

GenePOC Inc

GlucoSentient Inc

Group K Diagnostics

Illucidx Inc

Immuno-Mycologics Inc

Innova Biotechnology Co Ltd

Institute for Development Research

Institute of Molecular Biology of Parana

IPI Singapore

Johns Hopkins University

Kephera Diagnostics LLC

Labsystems Diagnostics Oy

Lynntech Inc

Makerere University

Meridian Bioscience Inc

Michigan State University

Micronics Inc

MiraVista Diagnostics LLC

Molbio Diagnostics Pvt Ltd

Mologic Ltd

MycoDART Inc

NanoRepro AG

NG Biotech

NOWDiagnostics Inc

Oasis Diagnostics Corp

OLM Diagnostics Ltd

Omega Diagnostics Group Plc

Oregon Health & Science University

PATH medical GmbH

Protein Advances Inc

Quidel Corp

Rutgers The State University of New Jersey

Salignostics Ltd

Scanogen Inc

Seattle Children's Hospital

Selfdiagnostics OU

Singapore Immunology Network

SoftRay Inc.

Tangen Biosciences Inc

Technical University of Munich

Trinity Biotech Plc

University of Antwerp

University of California, Merced

University of Delhi

University of Kansas Medical Center

University of Nevada Reno

University of Zurich

Ustar Biotechnologies (Hangzhou) Ltd.

Vanderbilt University

Whidiag SAS

Yaathum Biotech Pvt Ltd

Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 11

2 Introduction 12

2.1 Parasitology & Mycology Rapid Tests & POC Overview 12

3 Products under Development 13

3.1 Parasitology & Mycology Rapid Tests & POC – Pipeline Products by Stage of Development 13

3.2 Parasitology & Mycology Rapid Tests & POC – Pipeline Products by Territory 14

3.3 Parasitology & Mycology Rapid Tests & POC – Pipeline Products by Regulatory Path 15

3.4 Parasitology & Mycology Rapid Tests & POC – Pipeline Products by Estimated Approval Date 16

4 Parasitology & Mycology Rapid Tests & POC – Pipeline Products under Development by Companies 17

4.1 Parasitology & Mycology Rapid Tests & POC Companies – Pipeline Products by Stage of Development 17

4.2 Parasitology & Mycology Rapid Tests & POC – Pipeline Products by Stage of Development 20

5 Parasitology & Mycology Rapid Tests & POC Companies and Product Overview 23

5.1 Abingdon Health Ltd Company Overview 23

5.1.1 Abingdon Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.2 Access Bio Inc Company Overview 24

5.2.1 Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.3 AdvanDx Inc Company Overview 25

5.3.1 AdvanDx Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.4 Akers Biosciences Inc Company Overview 26

5.4.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.5 Ampath Trust Company Overview 27

5.5.1 Ampath Trust Pipeline Products & Ongoing Clinical Trials Overview 27

5.6 Amplino B.V. Company Overview 28

5.6.1 Amplino B.V. Pipeline Products & Ongoing Clinical Trials Overview 28

5.7 BBB Technologies Inc Company Overview 29

5.7.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 Binx Health Inc Company Overview 30

5.8.1 Binx Health Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.9 Biomagnetics Diagnostics Corp Company Overview 31

5.9.1 Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 31

5.10 Biopromic AB Company Overview 32

5.10.1 Biopromic AB Pipeline Products & Ongoing Clinical Trials Overview 32

5.11 Biotech Resources Aust Pty Ltd Company Overview 33

5.11.1 Biotech Resources Aust Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

5.12 Boston University Company Overview 35

5.12.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 35

5.13 Bruker Daltonik GmbH Company Overview 36

5.13.1 Bruker Daltonik GmbH Pipeline Products & Ongoing Clinical Trials Overview 36

5.14 Cepheid Inc Company Overview 37

5.14.1 Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.15 Ceres Nanosciences Inc Company Overview 38

5.15.1 Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.16 Chembio Diagnostic Systems Inc Company Overview 39

5.16.1 Chembio Diagnostic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.17 CrossLife Technologies Inc Company Overview 40

5.17.1 CrossLife Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.18 DetectoGen Inc Company Overview 43

5.18.1 DetectoGen Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.19 D-Kimia, LLC. Company Overview 44

5.19.1 D-Kimia, LLC. Pipeline Products & Ongoing Clinical Trials Overview 44

5.20 DxDiscovery Inc Company Overview 45

5.20.1 DxDiscovery Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.21 Eiken Chemical Co Ltd Company Overview 48

5.21.1 Eiken Chemical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

5.22 ERADA Technology Alliance Ltd Company Overview 50

5.22.1 ERADA Technology Alliance Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

5.23 Foundation for Innovative New Diagnostics Company Overview 51

5.23.1 Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 51

5.24 genedrive plc Company Overview 52

5.24.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 52

5.25 GenePOC Inc Company Overview 54

5.25.1 GenePOC Inc Pipeline Products & Ongoing Clinical Trials Overview 54

5.26 GlucoSentient Inc Company Overview 55

5.26.1 GlucoSentient Inc Pipeline Products & Ongoing Clinical Trials Overview 55

5.27 Group K Diagnostics Company Overview 56

5.27.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 56

5.28 Illucidx Inc Company Overview 57

5.28.1 Illucidx Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.29 Immuno-Mycologics Inc Company Overview 59

5.29.1 Immuno-Mycologics Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.30 Innova Biotechnology Co Ltd Company Overview 60

5.30.1 Innova Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

5.31 Institute for Development Research Company Overview 61

5.31.1 Institute for Development Research Pipeline Products & Ongoing Clinical Trials Overview 61

5.32 Institute of Molecular Biology of Parana Company Overview 63

5.32.1 Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview 63

5.33 IPI Singapore Company Overview 64

5.33.1 IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 64

5.34 Johns Hopkins University Company Overview 65

5.34.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 65

5.35 Kephera Diagnostics LLC Company Overview 67

5.35.1 Kephera Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 67

5.36 Labsystems Diagnostics Oy Company Overview 71

5.36.1 Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 71

5.37 Lynntech Inc Company Overview 72

5.37.1 Lynntech Inc Pipeline Products & Ongoing Clinical Trials Overview 72

5.38 Makerere University Company Overview 73

5.38.1 Makerere University Pipeline Products & Ongoing Clinical Trials Overview 73

5.39 Meridian Bioscience Inc Company Overview 74

5.39.1 Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 74

5.40 Michigan State University Company Overview 75

5.40.1 Michigan State University Pipeline Products & Ongoing Clinical Trials Overview 75

5.41 Micronics Inc Company Overview 76

5.41.1 Micronics Inc Pipeline Products & Ongoing Clinical Trials Overview 76

5.42 MiraVista Diagnostics LLC Company Overview 78

5.42.1 MiraVista Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 78

5.43 Molbio Diagnostics Pvt Ltd Company Overview 79

5.43.1 Molbio Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

5.44 Mologic Ltd Company Overview 81

5.44.1 Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview 81

5.45 MycoDART Inc Company Overview 83

5.45.1 MycoDART Inc Pipeline Products & Ongoing Clinical Trials Overview 83

5.46 NanoRepro AG Company Overview 84

5.46.1 NanoRepro AG Pipeline Products & Ongoing Clinical Trials Overview 84

5.47 NG Biotech Company Overview 85

5.47.1 NG Biotech Pipeline Products & Ongoing Clinical Trials Overview 85

5.48 NOWDiagnostics Inc Company Overview 87

5.48.1 NOWDiagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 87

5.49 Oasis Diagnostics Corp Company Overview 89

5.49.1 Oasis Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 89

5.50 OLM Diagnostics Ltd Company Overview 90

5.50.1 OLM Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

5.51 Omega Diagnostics Group Plc Company Overview 91

5.51.1 Omega Diagnostics Group Plc Pipeline Products & Ongoing Clinical Trials Overview 91

5.52 Oregon Health & Science University Company Overview 93

5.52.1 Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 93

5.53 PATH medical GmbH Company Overview 94

5.53.1 PATH medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 94

5.54 Protein Advances Inc Company Overview 95

5.54.1 Protein Advances Inc Pipeline Products & Ongoing Clinical Trials Overview 95

5.55 Quidel Corp Company Overview 96

5.55.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 96

5.56 Rutgers The State University of New Jersey Company Overview 97

5.56.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 97

5.57 Salignostics Ltd Company Overview 98

5.57.1 Salignostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 98

5.58 Scanogen Inc Company Overview 99

5.58.1 Scanogen Inc Pipeline Products & Ongoing Clinical Trials Overview 99

5.59 Seattle Children's Hospital Company Overview 100

5.59.1 Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 100

5.60 Selfdiagnostics OU Company Overview 101

5.60.1 Selfdiagnostics OU Pipeline Products & Ongoing Clinical Trials Overview 101

5.61 Singapore Immunology Network Company Overview 102

5.61.1 Singapore Immunology Network Pipeline Products & Ongoing Clinical Trials Overview 102

5.62 SoftRay Inc. Company Overview 103

5.62.1 SoftRay Inc. Pipeline Products & Ongoing Clinical Trials Overview 103

5.63 Tangen Biosciences Inc Company Overview 104

5.63.1 Tangen Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 104

5.64 Technical University of Munich Company Overview 106

5.64.1 Technical University of Munich Pipeline Products & Ongoing Clinical Trials Overview 106

5.65 Trinity Biotech Plc Company Overview 107

5.65.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 107

5.66 University of Antwerp Company Overview 108

5.66.1 University of Antwerp Pipeline Products & Ongoing Clinical Trials Overview 108

5.67 University of California, Merced Company Overview 109

5.67.1 University of California, Merced Pipeline Products & Ongoing Clinical Trials Overview 109

5.68 University of Delhi Company Overview 110

5.68.1 University of Delhi Pipeline Products & Ongoing Clinical Trials Overview 110

5.69 University of Kansas Medical Center Company Overview 111

5.69.1 University of Kansas Medical Center Pipeline Products & Ongoing Clinical Trials Overview 111

5.70 University of Nevada Reno Company Overview 112

5.70.1 University of Nevada Reno Pipeline Products & Ongoing Clinical Trials Overview 112

5.71 University of Zurich Company Overview 113

5.71.1 University of Zurich Pipeline Products & Ongoing Clinical Trials Overview 113

5.72 Ustar Biotechnologies (Hangzhou) Ltd. Company Overview 114

5.72.1 Ustar Biotechnologies (Hangzhou) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 114

5.73 Vanderbilt University Company Overview 115

5.73.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 115

5.74 Whidiag SAS Company Overview 116

5.74.1 Whidiag SAS Pipeline Products & Ongoing Clinical Trials Overview 116

5.75 Yaathum Biotech Pvt Ltd Company Overview 117

5.75.1 Yaathum Biotech Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 117

6 Parasitology & Mycology Rapid Tests & POC- Recent Developments 118

6.1 Mar 04, 2020: Ridgestone Mining hires Steve Weiss as chief independent technical advisor for Mexico 118

6.2 Jan 07, 2020: BIOASTER awarded Grant for the development of rapid diagnostics for neglected tropical diseases 118

6.3 Dec 05, 2019: CDC awards Aptagen $1MM contract for parasitic disease diagnostic 119

7 Appendix 120

7.1 Methodology 120

7.2 About GlobalData 124

7.3 Contact Us 124

List of Tables

Table 1: Parasitology & Mycology Rapid Tests & POC – Pipeline Products by Stage of Development 13

Table 2: Parasitology & Mycology Rapid Tests & POC – Pipeline Products by Territory 14

Table 3: Parasitology & Mycology Rapid Tests & POC – Pipeline Products by Regulatory Path 15

Table 4: Parasitology & Mycology Rapid Tests & POC – Pipeline Products by Estimated Approval Date 16

Table 5: Parasitology & Mycology Rapid Tests & POC Companies – Pipeline Products by Stage of Development 17

Table 6: Parasitology & Mycology Rapid Tests & POC – Pipeline Products by Stage of Development 20

Table 7: Abingdon Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Table 8: Rapid Molecular Diagnostic Test – Malaria – Product Status 23

Table 9: Rapid Molecular Diagnostic Test – Malaria – Product Description 23

Table 10: Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Table 11: ICT – Malaria RDT – Product Status 24

Table 12: ICT – Malaria RDT – Product Description 24

Table 13: AdvanDx Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Table 14: Candida QuickFISH – Product Status 25

Table 15: Candida QuickFISH – Product Description 25

Table 16: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Table 17: PIFA PLUSS Malaria Rapid Assay – Product Status 26

Table 18: PIFA PLUSS Malaria Rapid Assay – Product Description 26

Table 19: Ampath Trust Pipeline Products & Ongoing Clinical Trials Overview 27

Table 20: CAA UCP – LF Test Strip – Product Status 27

Table 21: CAA UCP – LF Test Strip – Product Description 27

Table 22: Amplino B.V. Pipeline Products & Ongoing Clinical Trials Overview 28

Table 23: Scout POC Assay – Product Status 28

Table 24: Scout POC Assay – Product Description 28

Table 25: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Table 26: Mobile RDT Reader – Malaria Test – Product Status 29

Table 27: Mobile RDT Reader – Malaria Test – Product Description 29

Table 28: Binx Health Inc Pipeline Products & Ongoing Clinical Trials Overview 30

Table 29: Atlas io System – Trichomonas Vaginalis – Product Status 30

Table 30: Atlas io System – Trichomonas Vaginalis – Product Description 30

Table 31: Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 31

Table 32: IOBS – Malaria Diagnostic Test – Product Status 31

Table 33: IOBS – Malaria Diagnostic Test – Product Description 31

Table 34: Biopromic AB Pipeline Products & Ongoing Clinical Trials Overview 32

Table 35: Lateral Flow Assay – Malaria – Product Status 32

Table 36: Lateral Flow Assay – Malaria – Product Description 32

Table 37: Biotech Resources Aust Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

Table 38: ATR – FTIR System – Malaria – Product Status 33

Table 39: ATR – FTIR System – Malaria – Product Description 33

Table 40: ATR-FTIR System – Babesia – Product Status 34

Table 41: ATR-FTIR System – Babesia – Product Description 34

Table 42: Boston University Pipeline Products & Ongoing Clinical Trials Overview 35

Table 43: Rapid Paperfluidic Test – Trichomonas Vaginalis – Product Status 35

Table 44: Rapid Paperfluidic Test – Trichomonas Vaginalis – Product Description 35

Table 45: Bruker Daltonik GmbH Pipeline Products & Ongoing Clinical Trials Overview 36

Table 46: MALDI Biotyper – Fungal Infection – Product Status 36

Table 47: MALDI Biotyper – Fungal Infection – Product Description 36

Table 48: Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Table 49: Point Of Care Test – Fungi Infections – Product Status 37

Table 50: Point Of Care Test – Fungi Infections – Product Description 37

Table 51: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Table 52: Nanotrap Malaria Test – Product Status 38

Table 53: Nanotrap Malaria Test – Product Description 38

Table 54: Chembio Diagnostic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Table 55: DPP Malaria – Product Status 39

Table 56: DPP Malaria – Product Description 39

Table 57: CrossLife Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 40

Table 58: Point Of Care Nucleic Acid Test – Liver Fluke – Product Status 40

Table 59: Point Of Care Nucleic Acid Test – Liver Fluke – Product Description 40

Table 60: Point Of Care Test – Malaria – Product Status 41

Table 61: Point Of Care Test – Malaria – Product Description 41

Table 62: Point-Of-Care Diagnostic Assay – Dengue – Product Status 41

Table 63: Point-Of-Care Diagnostic Assay – Dengue – Product Description 42

Table 64: DetectoGen Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Table 65: Antigen Detection Test – Visceral Leishmaniasis – Product Status 43

Table 66: Antigen Detection Test – Visceral Leishmaniasis – Product Description 43

Table 67: D-Kimia, LLC. Pipeline Products & Ongoing Clinical Trials Overview 44

Table 68: Diagnostic Assay – Malaria – Product Status 44

Table 69: Diagnostic Assay – Malaria – Product Description 44

Table 70: DxDiscovery Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Table 71: Diagnostic Assay – Candidiasis – Product Status 45

Table 72: Diagnostic Assay – Candidiasis – Product Description 45

Table 73: Diagnostic Assay – Crytococcosis – Product Status 46

Table 74: Diagnostic Assay – Crytococcosis – Product Description 46

Table 75: Diagnostic Assay – Mucormycosis – Product Status 46

Table 76: Diagnostic Assay – Mucormycosis – Product Description 47

Table 77: Diagnostic Assay – Tinea Capitis – Product Status 47

Table 78: Diagnostic Assay – Tinea Capitis – Product Description 47

Table 79: Eiken Chemical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

Table 80: LAMP Test – Chagas Disease – Product Status 48

Table 81: LAMP Test – Chagas Disease – Product Description 49

Table 82: Ov16/Wb123 Biplex Rapid Test – Product Status 49

Table 83: Ov16/Wb123 Biplex Rapid Test – Product Description 49

Table 84: ERADA Technology Alliance Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

Table 85: SMAART – Product Status 50

Table 86: SMAART – Product Description 50

Table 87: Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 51

Table 88: P. vivax Serology Test – Product Status 51

Table 89: P. vivax Serology Test – Product Description 51

Table 90: genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 52

Table 91: Genedrive – Malaria Assay – Product Status 52

Table 92: Genedrive – Malaria Assay – Product Description 52

Table 93: Genedrive – Parasite Infections Assay – Product Status 53

Table 94: Genedrive – Parasite Infections Assay – Product Description 53

Table 95: GenePOC Inc Pipeline Products & Ongoing Clinical Trials Overview 54

Table 96: revogene – Candida albicans Assay – Product Status 54

Table 97: revogene – Candida albicans Assay – Product Description 54

Table 98: GlucoSentient Inc Pipeline Products & Ongoing Clinical Trials Overview 55

Table 99: Point-Of-Care Screening Assay – Fungal Infections – Product Status 55

Table 100: Point-Of-Care Screening Assay – Fungal Infections – Product Description 55

Table 101: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 56

Table 102: Multidiagnostic – Malaria Test – Product Status 56

Table 103: Multidiagnostic – Malaria Test – Product Description 56

Table 104: Illucidx Inc Pipeline Products & Ongoing Clinical Trials Overview 57

Table 105: Diagnostic Test – Dengue – Product Status 57

Table 106: Diagnostic Test – Dengue – Product Description 57

Table 107: Malaria Dx – Product Status 58

Table 108: Malaria Dx – Product Description 58

Table 109: Immuno-Mycologics Inc Pipeline Products & Ongoing Clinical Trials Overview 59

Table 110: Lateral Flow Assay – Histoplasmosis – Product Status 59

Table 111: Lateral Flow Assay – Histoplasmosis – Product Description 59

Table 112: Innova Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

Table 113: Rapid Test – Malaria – Product Status 60

Table 114: Rapid Test – Malaria – Product Description 60

Table 115: Institute for Development Research Pipeline Products & Ongoing Clinical Trials Overview 61

Table 116: Diagnostic Test – Amebiasis – Product Status 61

Table 117: Diagnostic Test – Amebiasis – Product Description 61

Table 118: Rapid Diagnostic Test – American Tegumentary Leishmaniasis – Product Status 62

Table 119: Rapid Diagnostic Test – American Tegumentary Leishmaniasis – Product Description 62

Table 120: Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview 63

Table 121: Point-of-Care Diagnostic Test – Chagas Disease – Product Status 63

Table 122: Point-of-Care Diagnostic Test – Chagas Disease – Product Description 63

Table 123: IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 64

Table 124: Diagnostic Test – Malaria – Product Status 64

Table 125: Diagnostic Test – Malaria – Product Description 64

Table 126: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 65

Table 127: Nanoparticle Diagnostic Assay – Chagas Disease – Product Status 65

Table 128: Nanoparticle Diagnostic Assay – Chagas Disease – Product Description 65

Table 129: Nanoparticle Diagnostic Assay – Toxoplasmic Encephalitis – Product Status 66

Table 130: Nanoparticle Diagnostic Assay – Toxoplasmic Encephalitis – Product Description 66

Table 131: Kephera Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 67

Table 132: Biomarker Based Test – Chagas Disease – Product Status 67

Table 133: Biomarker Based Test – Chagas Disease – Product Description 67

Table 134: Lateral Flow Assay – OVCS – Product Status 68

Table 135: Lateral Flow Assay – OVCS – Product Description 68

Table 136: Point Of Care Test – OVCS – Product Status 68

Table 137: Point Of Care Test – OVCS – Product Description 69

Table 138: Point-Of-Care Test – Cysticercosis – Product Status 69

Table 139: Point-Of-Care Test – Cysticercosis – Product Description 69

Table 140: Point-Of-Care Test – Neurocysticercosis – Product Status 70

Table 141: Point-Of-Care Test – Neurocysticercosis – Product Description 70

Table 142: Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 71

Table 143: Biocard Malaria Test – Product Status 71

Table 144: Biocard Malaria Test – Product Description 71

Table 145: Lynntech Inc Pipeline Products & Ongoing Clinical Trials Overview 72

Table 146: NTDx-S Diagnostic Assay – Product Status 72

Table 147: NTDx-S Diagnostic Assay – Product Description 72

Table 148: Makerere University Pipeline Products & Ongoing Clinical Trials Overview 73

Table 149: Rapid Diagnostic Test – African Trypanosomiasis – Product Status 73

Table 150: Rapid Diagnostic Test – African Trypanosomiasis – Product Description 73

Table 151: Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 74

Table 152: Illumigene Babesia Assay – Product Status 74

Table 153: Illumigene Babesia Assay – Product Description 74

Table 154: Michigan State University Pipeline Products & Ongoing Clinical Trials Overview 75

Table 155: Antibody-Based Lateral Flow Assay – Malaria – Product Status 75

Table 156: Antibody-Based Lateral Flow Assay – Malaria – Product Description 75

Table 157: Micronics Inc Pipeline Products & Ongoing Clinical Trials Overview 76

Table 158: PanNAT – Malaria Assay – Product Status 76

Table 159: PanNAT – Malaria Assay – Product Description 76

Table 160: PanNAT – TV Assay – Product Status 77

Table 161: PanNAT – TV Assay – Product Description 77

Table 162: MiraVista Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 78

Table 163: Rapid Diagnostic Test – Coccidioidomycosis – Product Status 78

Table 164: Rapid Diagnostic Test – Coccidioidomycosis – Product Description 78

Table 165: Molbio Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

Table 166: Truenat Leishmaniasis Assay – Product Status 79

Table 167: Truenat Leishmaniasis Assay – Product Description 79

Table 168: Truenat Toxoplasma Gondii Assay – Product Status 80

Table 169: Truenat Toxoplasma Gondii Assay – Product Description 80

Table 170: Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview 81

Table 171: Diagnostic Test – Malaria – Product Status 81

Table 172: Diagnostic Test – Malaria – Product Description 81

Table 173: Rapid Diagnostic Test – Onchocerciasis – Product Status 82

Table 174: Rapid Diagnostic Test – Onchocerciasis – Product Description 82

Table 175: MycoDART Inc Pipeline Products & Ongoing Clinical Trials Overview 83

Table 176: MycoDART-PCR Candida Diagnostic Panel – Product Status 83

Table 177: MycoDART-PCR Candida Diagnostic Panel – Product Description 83

Table 178: NanoRepro AG Pipeline Products & Ongoing Clinical Trials Overview 84

Table 179: Rapid Diagnostic Test – Malaria – Product Status 84

Table 180: Rapid Diagnostic Test – Malaria – Product Description 84

Table 181: NG Biotech Pipeline Products & Ongoing Clinical Trials Overview 85

Table 182: NG-Quant Pf/Malaria Test – Product Status 85

Table 183: NG-Quant Pf/Malaria Test – Product Description 85

Table 184: NG-Telediag pf/Pan Test – Product Status 86

Table 185: NG-Telediag pf/Pan Test – Product Description 86

Table 186: NOWDiagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 87

Table 187: ADEXUSDx Test – Malaria – Product Status 87

Table 188: ADEXUSDx Test – Malaria – Product Description 87

Table 189: ADEXUSDx Trichomoniasis Test – Product Status 88

Table 190: ADEXUSDx Trichomoniasis Test – Product Description 88

Table 191: Oasis Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 89

Table 192: SALVA! – Product Status 89

Table 193: SALVA! – Product Description 89

Table 194: OLM Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

Table 195: Point Of Care Diagnostic Test – Fungal Infection – Product Status 90

Table 196: Point Of Care Diagnostic Test – Fungal Infection – Product Description 90

Table 197: Omega Diagnostics Group Plc Pipeline Products & Ongoing Clinical Trials Overview 91

Table 198: SmCTF-RDT – Product Status 91

Table 199: SmCTF-RDT – Product Description 91

Table 200: VISITECT CD4 Advanced Disease Test – Malaria – Product Status 92

Table 201: VISITECT CD4 Advanced Disease Test – Malaria – Product Description 92

Table 202: Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 93

Table 203: Point-Of-Care Assay – Subarachnoid Neurocysticercosis – Product Status 93

Table 204: Point-Of-Care Assay – Subarachnoid Neurocysticercosis – Product Description 93

Table 205: PATH medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 94

Table 206: PATH Chagas Immunochromatographic Strip Test – Product Status 94

Table 207: PATH Chagas Immunochromatographic Strip Test – Product Description 94

Table 208: Protein Advances Inc Pipeline Products & Ongoing Clinical Trials Overview 95

Table 209: Diagnostic Test – Human African Trypanosomiasis – Product Status 95

Table 210: Diagnostic Test – Human African Trypanosomiasis – Product Description 95

Table 211: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 96

Table 212: Fungal Infection Assay – Product Status 96

Table 213: Fungal Infection Assay – Product Description 96

Table 214: Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 97

Table 215: Rapid Diagnostic Assay – Tick-borne Diseases – Product Status 97

Table 216: Rapid Diagnostic Assay – Tick-borne Diseases – Product Description 97

Table 217: Salignostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 98

Table 218: Rapid Diagnostic Test – Malaria – Product Status 98

Table 219: Rapid Diagnostic Test – Malaria – Product Description 98

Table 220: Scanogen Inc Pipeline Products & Ongoing Clinical Trials Overview 99

Table 221: SMS-Fungi – Product Status 99

Table 222: SMS-Fungi – Product Description 99

Table 223: Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 100

Table 224: Diagnostic Test – Malaria – Product Status 100

Table 225: Diagnostic Test – Malaria – Product Description 100

Table 226: Selfdiagnostics OU Pipeline Products & Ongoing Clinical Trials Overview 101

Table 227: Intime – Malaria – Product Status 101

Table 228: Intime – Malaria – Product Description 101

Table 229: Singapore Immunology Network Pipeline Products & Ongoing Clinical Trials Overview 102

Table 230: Rapid Diagnostic Assay – Malaria – Product Status 102

Table 231: Rapid Diagnostic Assay – Malaria – Product Description 102

Table 232: SoftRay Inc. Pipeline Products & Ongoing Clinical Trials Overview 103

Table 233: Point-Of-Care System – Candidemia – Product Status 103

Table 234: Point-Of-Care System – Candidemia – Product Description 103

Table 235: Tangen Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 104

Table 236: Skin-Swab Based Test – Candida Auris – Product Status 104

Table 237: Skin-Swab Based Test – Candida Auris – Product Description 104

Table 238: TangenDx Direct – Product Status 105

Table 239: TangenDx Direct – Product Description 105

Table 240: Technical University of Munich Pipeline Products & Ongoing Clinical Trials Overview 106

Table 241: Malaria Blood Test – Product Status 106

Table 242: Malaria Blood Test – Product Description 106

Table 243: Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 107

Table 244: Screening Test – Malaria – Product Status 107

Table 245: Screening Test – Malaria – Product Description 107

Table 246: University of Antwerp Pipeline Products & Ongoing Clinical Trials Overview 108

Table 247: POC Test – Fungal Infection – Product Status 108

Table 248: POC Test – Fungal Infection – Product Description 108

Table 249: University of California, Merced Pipeline Products & Ongoing Clinical Trials Overview 109

Table 250: Diagnostic Test – Valley Fever – Product Status 109

Table 251: Diagnostic Test – Valley Fever – Product Description 109

Table 252: University of Delhi Pipeline Products & Ongoing Clinical Trials Overview 110

Table 253: Rapid Diagnostic Kit – Trichomonas Vaginalis – Product Status 110

Table 254: Rapid Diagnostic Kit – Trichomonas Vaginalis – Product Description 110

Table 255: University of Kansas Medical Center Pipeline Products & Ongoing Clinical Trials Overview 111

Table 256: Diagnostic Test – Histoplasmosis – Product Status 111

Table 257: Diagnostic Test – Histoplasmosis – Product Description 111

Table 258: University of Nevada Reno Pipeline Products & Ongoing Clinical Trials Overview 112

Table 259: Diagnostic Assay – Aspergillosis – Product Status 112

Table 260: Diagnostic Assay – Aspergillosis – Product Description 112

Table 261: University of Zurich Pipeline Products & Ongoing Clinical Trials Overview 113

Table 262: Diagnostic Test Kit – Dermatophyte Infections – Product Status 113

Table 263: Diagnostic Test Kit – Dermatophyte Infections – Product Description 113

Table 264: Ustar Biotechnologies (Hangzhou) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 114

Table 265: RT CPA – TV Test – Product Status 114

Table 266: RT CPA – TV Test – Product Description 114

Table 267: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 115

Table 268: Point-of-Care Biomarker Test – Malaria – Product Status 115

Table 269: Point-of-Care Biomarker Test – Malaria – Product Description 115

Table 270: Whidiag SAS Pipeline Products & Ongoing Clinical Trials Overview 116

Table 271: Rapid Diagnostic Test – Leishmaniasis – Product Status 116

Table 272: Rapid Diagnostic Test – Leishmaniasis – Product Description 116

Table 273: Yaathum Biotech Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 117

Table 274: Rapid Diagnostic Test – Malaria – Product Status 117

Table 275: Rapid Diagnostic Test – Malaria – Product Description 117

List of Figures

Figure 1: Parasitology & Mycology Rapid Tests & POC – Pipeline Products by Stage of Development 13

Figure 2: Parasitology & Mycology Rapid Tests & POC – Pipeline Products by Territory 14

Figure 3: Parasitology & Mycology Rapid Tests & POC – Pipeline Products by Regulatory Path 15

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports